menu
    • menu
    [{"orgOrder":0,"company":"Tereos","sponsor":"CEN Biotech","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"SPAIN","productType":"Probiotic","year":"2024","type":"Inapplicable","leadProduct":"Fructo-Oligosaccharide","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Undisclosed","graph3":"Tereos","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Tereos \/ CEN Biotech","highestDevelopmentStatusID":"1","companyTruncated":"Tereos \/ CEN Biotech"},{"orgOrder":0,"company":"Tereos","sponsor":"BioFortis","pharmaFlowCategory":"DU","therapeuticArea":"Endocrinology","country":"SPAIN","productType":"Dietary Supplement","year":"2021","type":"Inapplicable","leadProduct":"Non Digestible Carbohydrates","moa":"Undisclosed","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"Tereos","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Tereos \/ BioFortis","highestDevelopmentStatusID":"1","companyTruncated":"Tereos \/ BioFortis"}]

    Find Clinical Drug Pipeline Developments & Deals by Tereos

    Menu

    Tereos

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    EXCIPIENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Tereos

                            Spain arrow
                            SupplySide West
                            Not Confirmed

                            Tereos

                            Spain arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Fructo-Oligosaccharide

                            Therapeutic Area : Undisclosed

                            Study Phase : Undisclosed

                            Sponsor : CEN Biotech

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Evaluation of Gastrointestinal Comfort Following Regular Consumption of Short-chain Fructo-oligosaccharides (1...

                            Details : Fructo-Oligosaccharide is a Probiotic drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Probiotic

                            Upfront Cash : Inapplicable

                            January 12, 2024

                            Lead Product(s) : Fructo-Oligosaccharide

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Undisclosed

                            Sponsor : CEN Biotech

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Tereos

                            Spain arrow
                            SupplySide West
                            Not Confirmed

                            Tereos

                            Spain arrow
                            SupplySide West
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Non Digestible Carbohydrates

                            Therapeutic Area : Endocrinology

                            Study Phase : Undisclosed

                            Sponsor : BioFortis

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Study to Assess the Effects of Non Digestible Carbohydrates on Long-Term Glucose Homeostasis in Untreated Pred...

                            Details : Non Digestible Carbohydrates is a Dietary Supplement drug candidate, which is currently being evaluated in clinical studies for the treatment of Prediabetic State.

                            Product Name : Undisclosed

                            Product Type : Dietary Supplement

                            Upfront Cash : Inapplicable

                            February 23, 2021

                            Lead Product(s) : Non Digestible Carbohydrates

                            Therapeutic Area : Endocrinology

                            Highest Development Status : Undisclosed

                            Sponsor : BioFortis

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth